smpc semaglutide Switching between weight-loss medications Semaglutide for weight loss |

This lets you focus entirely on your science

GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)

Each Cerelac product contained nearly 6 g of added sugar per serving, with the highest average level at 7.3 g per serving

Still useful in a multi-lever approach because it is inexpensive and has a long safety record (with appropriate monitoring and contraindications respected)